SK23594A3 - Sustained release organic nitrite therapy - Google Patents

Sustained release organic nitrite therapy Download PDF

Info

Publication number
SK23594A3
SK23594A3 SK235-94A SK23594A SK23594A3 SK 23594 A3 SK23594 A3 SK 23594A3 SK 23594 A SK23594 A SK 23594A SK 23594 A3 SK23594 A3 SK 23594A3
Authority
SK
Slovakia
Prior art keywords
nitrite
patient
therapy
heart failure
congestive heart
Prior art date
Application number
SK235-94A
Other languages
English (en)
Slovak (sk)
Inventor
Ho-Leung Fung
John A Bauer
Original Assignee
Baker Norton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Norton Pharma filed Critical Baker Norton Pharma
Publication of SK23594A3 publication Critical patent/SK23594A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK235-94A 1992-07-02 1993-06-30 Sustained release organic nitrite therapy SK23594A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/908,224 US5278192A (en) 1992-07-02 1992-07-02 Method of vasodilator therapy for treating a patient with a condition
PCT/US1993/006235 WO1994001103A1 (fr) 1992-07-02 1993-06-30 Therapie au nitrite organique a liberation prolongee

Publications (1)

Publication Number Publication Date
SK23594A3 true SK23594A3 (en) 1994-08-10

Family

ID=25425396

Family Applications (1)

Application Number Title Priority Date Filing Date
SK235-94A SK23594A3 (en) 1992-07-02 1993-06-30 Sustained release organic nitrite therapy

Country Status (19)

Country Link
US (2) US5278192A (fr)
EP (1) EP0604642A1 (fr)
JP (1) JP2729333B2 (fr)
KR (1) KR0170789B1 (fr)
CN (1) CN1086997A (fr)
AU (1) AU667948B2 (fr)
CA (1) CA2116785C (fr)
CZ (1) CZ39894A3 (fr)
HU (1) HUT70501A (fr)
IL (1) IL106217A (fr)
MX (1) MX9303982A (fr)
NO (1) NO305886B1 (fr)
NZ (1) NZ254490A (fr)
OA (1) OA09890A (fr)
PL (1) PL302613A1 (fr)
SK (1) SK23594A3 (fr)
TW (1) TW261530B (fr)
WO (1) WO1994001103A1 (fr)
ZA (1) ZA934771B (fr)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition
US5646181A (en) * 1992-07-02 1997-07-08 Research Foundation Of State University Of New York Method and compositions for treating impotence
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
US5973011A (en) * 1994-03-30 1999-10-26 Isis Pharma Gmbh Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
US5594032A (en) * 1994-11-10 1997-01-14 Gonzalez-Cadavid; Nestor F. Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA
US5665077A (en) * 1995-04-24 1997-09-09 Nitrosci Pharmaceuticals Llc Nitric oxide-releasing nitroso compositions and methods and intravascular devices for using them to prevent restenosis
US5645839A (en) * 1995-06-07 1997-07-08 Trustees Of Boston University Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis
US5658936A (en) * 1995-09-18 1997-08-19 Brigham & Women's Hospital, Inc. Enhancement of erectile function with renin-angiotensin system inhibitors
US6387407B1 (en) 1995-09-29 2002-05-14 L.A.M. Pharmaceutical Corporation Topical drug preparations
US6251436B1 (en) 1995-09-29 2001-06-26 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US5897880A (en) 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
US6036977A (en) * 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
WO1997027745A1 (fr) * 1996-01-31 1997-08-07 Technology Licensing Co. L.L.C. Procede de diagnostic et de traitement, compositions et appareils connexes
US6258032B1 (en) * 1997-01-29 2001-07-10 William M. Hammesfahr Method of diagnosis and treatment and related compositions and apparatus
GB9608408D0 (en) 1996-04-23 1996-06-26 Adams Michael A Treatment of erectile dysfunction
US5797887A (en) * 1996-08-27 1998-08-25 Novovasc Llc Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation
US5958884A (en) * 1997-04-11 1999-09-28 The Brigham And Women's Hospital, Inc. Compositions and methods for treating erectile dysfunction
US6191156B1 (en) 1997-04-11 2001-02-20 The Brigham And Women's Hospital, Inc. Compositions and methods for treating bladder dysfunction
ZA989356B (en) * 1997-10-16 1998-11-16 Isis Pharma Gmbh Pharmaceutical preparations
US6056966A (en) * 1998-05-18 2000-05-02 Baker Norton Pharmaceuticals, Inc. Method and compositions for treating impotence
US6314956B1 (en) * 1999-09-08 2001-11-13 Duke University Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders
US7045152B2 (en) 1999-09-08 2006-05-16 Duke University Treating pulmonary disorders with gaseous agent causing repletion of GSNO
CA2410632A1 (fr) 2000-06-22 2001-12-27 David S. Garvey Taxanes nitroses et nitrosyles, compositions et procedes d'utilisation
WO2002013982A1 (fr) 2000-08-11 2002-02-21 Whitlock David R Compositions a base de bacteries oxydant l'ammoniac pour augmenter la production d'oxyde nitrique et de precurseurs d'oxyde nitrique et procedes d'utilisation
US20020172712A1 (en) * 2001-03-19 2002-11-21 Alan Drizen Antiemetic, anti-motion sustained release drug delivery system
US7235523B2 (en) * 2001-04-13 2007-06-26 Children's Hospital Medical Center Methods for the treatment of hepatic disorders
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030138494A1 (en) * 2001-05-15 2003-07-24 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US6676855B2 (en) * 2001-08-02 2004-01-13 Duke University Use of a blood-flow decrease preventing agent in conjunction with insufflating gas
US20040225275A1 (en) * 2001-08-02 2004-11-11 Reynolds James Dixon Fetal physiology during maternal surgery or diagnosis
US20050244382A9 (en) * 2002-01-11 2005-11-03 Whitlock David R Compositions including ammonia oxidizing bacteria and methods of using same
AU2003210808A1 (en) 2002-03-06 2003-09-22 Duke University Methods and composition based on discovery of metabolism of nitroclycerin
US7776925B2 (en) * 2002-03-06 2010-08-17 Duke University Reversing, postponing or preventing the occurrence of GTN tolerance and/or generation of reactive oxygen species from mitochondria
US20060263419A1 (en) * 2002-03-12 2006-11-23 Hans-Michael Wolff Transdermal therapeutic system for Parkinson's Disease
US8822473B2 (en) * 2002-05-21 2014-09-02 Gilead Sciences, Inc. Method of treating diabetes
AU2003248558B8 (en) 2002-05-21 2009-07-09 Gilead Sciences, Inc. Method of treating diabetes
US6936639B2 (en) * 2002-08-21 2005-08-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitroxyl progenitors in the treatment of heart failure
WO2005063221A1 (fr) * 2003-12-19 2005-07-14 Duke University Mesure de l'activite vasodilatatrice d'echantillons de sang pour faire le suivi de l'evolution d'une pathologie
EP1865770A4 (fr) * 2005-04-07 2010-12-29 Nitromed Inc Evaluation du risque genetique d'insuffisance cardiaque: impact de la variation genetique de nos3
CA2610922A1 (fr) * 2005-06-13 2006-12-21 Yeda Research And Development Co. Ltd. Utilisation d'allylmercaptocaptopril pour traiter ou prevenir l'obesite et des maladies associees a l'obesite
WO2007041681A2 (fr) * 2005-10-04 2007-04-12 Nitromed, Inc. Méthodes de traitement de troubles respiratoires
US8030511B2 (en) * 2006-03-14 2011-10-04 Gustafsson Lars E Method for the manufacture of therapeutic compounds and compositions, compounds and compositions produced therewith, and their use
US7625852B2 (en) * 2006-06-07 2009-12-01 Henry Hadry Nail polish remover
US9259535B2 (en) 2006-06-22 2016-02-16 Excelsior Medical Corporation Antiseptic cap equipped syringe
US11229746B2 (en) 2006-06-22 2022-01-25 Excelsior Medical Corporation Antiseptic cap
WO2009065142A2 (fr) 2007-11-15 2009-05-22 Biomedical Research Foundation Of Northwest Louisiana Utilisation de sels de nitrite dans l'ischémie chronique
US9078992B2 (en) 2008-10-27 2015-07-14 Pursuit Vascular, Inc. Medical device for applying antimicrobial to proximal end of catheter
WO2010147742A2 (fr) 2009-06-18 2010-12-23 Theravasc Inc. Utilisation de sels de nitrates dans le traitement d'un endommagement tissulaire
CA2777066C (fr) 2009-10-14 2020-02-18 TheraVasc, LLC Formulations pharmaceutiques de nitrite et utilisations de celle-ci
WO2011063339A1 (fr) * 2009-11-23 2011-05-26 Cardioxyl Pharmaceuticals, Inc. Donneurs de nitroxyle destinés au traitement de l'hypertension pulmonaire
WO2011071947A2 (fr) * 2009-12-07 2011-06-16 Johns Hopkins University Dérivés d'hydroxylamine bis-acylée
CA2782110A1 (fr) * 2009-12-07 2011-06-16 Johns Hopkins University Derives de n-acyloxysulfonamide et de n-hydroxy-n-acylsulfonamide
US10166381B2 (en) 2011-05-23 2019-01-01 Excelsior Medical Corporation Antiseptic cap
WO2013009998A2 (fr) 2011-07-12 2013-01-17 Pursuit Vascular, Inc. Dispositif de distribution d'agent antimicrobien dans cathéter transdermique
RU2015105097A (ru) * 2012-08-23 2016-10-10 Кардиолинкс Аг Композиции аминоалкилнитрата с пролонгированным высвобождением
EP2958573B1 (fr) 2013-02-20 2019-05-08 The Board of Supervisors of the Louisiana State University Mechanical and Agricultural College Formulations pharmaceutiques de nitrite et leurs utilisations
CA2946050C (fr) 2014-04-15 2023-08-29 Aobiome Llc Souche d23 de nitrosomonas eutropha oxydant l'ammoniac
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis
EP3137122B1 (fr) 2014-05-02 2019-09-04 Excelsior Medical Corporation Emballage de bande pour bouchon antiseptique
JP6822978B2 (ja) 2015-05-08 2021-01-27 アイシーユー・メディカル・インコーポレーテッド 治療薬のエミッタを受け入れるように構成された医療用コネクタ
CA3040277A1 (fr) 2016-10-14 2018-04-19 Icu Medical, Inc. Capuchons desinfectants pour raccords medicaux
WO2018204206A2 (fr) 2017-05-01 2018-11-08 Icu Medical, Inc. Raccords de fluide médical et procédés pour fournir des additifs dans des conduites de fluide médical
US11400195B2 (en) 2018-11-07 2022-08-02 Icu Medical, Inc. Peritoneal dialysis transfer set with antimicrobial properties
US11534595B2 (en) 2018-11-07 2022-12-27 Icu Medical, Inc. Device for delivering an antimicrobial composition into an infusion device
US11541220B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Needleless connector with antimicrobial properties
US11541221B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Tubing set with antimicrobial properties
US11517732B2 (en) 2018-11-07 2022-12-06 Icu Medical, Inc. Syringe with antimicrobial properties
AU2019384564B2 (en) 2018-11-21 2023-11-23 Icu Medical, Inc. Antimicrobial device comprising a cap with ring and insert
GB2579240B (en) * 2018-11-27 2020-12-16 Attgeno Ab New processes, compositions and medical uses
GB202007929D0 (en) * 2020-05-27 2020-07-08 Attgeno Ab New medical uses
WO2022072663A1 (fr) * 2020-10-01 2022-04-07 Emergent Product Development Gaithersburg Inc. Compositions stabilisées de nitrite d'alkyle
CA3204371A1 (fr) 2020-12-07 2022-06-16 Icu Medical, Inc. Capuchons, systemes et procedes de dialyse peritoneale

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3106511A (en) * 1961-12-14 1963-10-08 Revlon Amyl nitrite inhalant composition
CA1163195A (fr) * 1980-06-26 1984-03-06 Alec D. Keith Milieu de diffusion polymerique contenant un vasodilatateur
US4450175A (en) * 1982-09-23 1984-05-22 Warshaw Thelma G Method and compositions for treating acne
DE3305690A1 (de) * 1983-02-18 1984-08-30 Heinrich Mack Nachf., 7918 Illertissen Glycerinmononitrate zur behandlung der angina pectoris
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
US4681584A (en) * 1985-05-03 1987-07-21 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
US4615699A (en) * 1985-05-03 1986-10-07 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
JPH06696B2 (ja) * 1987-01-27 1994-01-05 積水化学工業株式会社 テ−プ製剤
JPH06697B2 (ja) * 1987-01-27 1994-01-05 積水化学工業株式会社 テ−プ製剤
US4956181A (en) * 1987-05-08 1990-09-11 Eastman Kodak Nitrate therapy for angina pectoris
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition

Also Published As

Publication number Publication date
NO940691D0 (no) 1994-02-28
JPH06510800A (ja) 1994-12-01
CZ39894A3 (en) 1994-11-16
TW261530B (fr) 1995-11-01
JP2729333B2 (ja) 1998-03-18
NO305886B1 (no) 1999-08-16
PL302613A1 (en) 1994-09-05
IL106217A (en) 1998-04-05
EP0604642A1 (fr) 1994-07-06
AU667948B2 (en) 1996-04-18
CA2116785C (fr) 1998-04-07
CA2116785A1 (fr) 1994-01-20
HU9400627D0 (en) 1994-06-28
KR0170789B1 (ko) 1999-02-01
US5278192A (en) 1994-01-11
CN1086997A (zh) 1994-05-25
AU4658793A (en) 1994-01-31
ZA934771B (en) 1994-01-20
IL106217A0 (en) 1993-11-15
NO940691L (no) 1994-03-18
HUT70501A (en) 1995-10-30
MX9303982A (es) 1994-02-28
US5489610A (en) 1996-02-06
NZ254490A (en) 1997-08-22
OA09890A (en) 1994-09-15
WO1994001103A1 (fr) 1994-01-20

Similar Documents

Publication Publication Date Title
SK23594A3 (en) Sustained release organic nitrite therapy
CN101370486B (zh) 含有硝酸异山梨酯和比索洛尔的透皮贴剂
EP0490891A4 (en) Drug containing matrix
JPH09505807A (ja) プリン組成物および投与方法
US20220096417A1 (en) Induction of arteriogenesis with an no (nitric oxide) donor
US4416893A (en) Substituted 1,2,5-oxadiazole-2-oxides in human cardiovascular system disease
JP3119430B2 (ja) 水酸基ラジカル消去剤
JPH08509749A (ja) 活性物質投与用の経皮治療システム
Corwin et al. Nitrate therapy for angina pectoris: current concepts about mechanism of action and evaluation of currently available preparations
JPS5888312A (ja) カルニチンまたは低級アシルカルニチンからなる静脈疾患治療剤
ES2234933T3 (es) Utilizacion de opiaceos debiles y mixtos agonistas/antagonistas para el tratamiento de la incontinencia urinaria.
ES2260306T3 (es) Utilizacion de compuestos 6-dimetilaminometil-1-fenilciclohexano para el tratamiento de incontinencia urinaria.
JPS6129927B2 (fr)
Stacher et al. Effects of 3‐days' intake of a sustained‐release preparation of the nitric oxide donor, isosorbide dinitrate, on oesophageal motility
TW202027744A (zh) 胺基甲酸酯化合物於預防、緩解或治療糖尿病周邊神經病變或化療誘發的周邊神經病變的用途
ES2267796T3 (es) Uso de fibratos para la preparacion de un medicamento util en el tratamiento de insuficiencia cardiaca congestiva.
SU1664323A1 (ru) Кардиопротекторное средство "Милдронат
KR20130040862A (ko) 과민성 대장 증후군의 치료를 위한 방법 및 조성물
JP2000219626A (ja) ケロイドおよび／または肥厚性瘢痕の治療剤
US4179521A (en) L- and DL-Phenylglycines to treat diseases or conditions attributable to reduced carbohydrate metabolism
US4185117A (en) Method of treatment with glycinamides
Stewart et al. Discrepancy between initial and steady-state resistance vessel responsiveness to short-term nitroglycerin exposure in the hindlimb of conscious dogs
US5326774A (en) Pharmaceutical preparation of antihypertensive, antianginal, antiarrhythmic and antiglaucomic action
Kumar 2-Chloroprocaine and Bupivacaine for lower abdomen and lower limb surgeries under spinal anesthesia: Effects on Haemodynamics
WO2022157563A1 (fr) Composition pharmaceutique comprenant de la lidocaïne et de la mélatonine